BioStock Investor Pitch: ExpreS2ion Biotechnologies

BioStock invites you to watch ExpreS2ion Biotechnologies' company presentation today at 10:00. The company develops protein-based vaccines using its platform technology ExpreS2. Today, the pipeline consists of projects in four indications: covid-19, breast cancer, influenza and malaria. The company is currently carrying out a rights issue of 73 million SEK to finance the completion of preclinical studies within the breast cancer project ES2B-C001, as well as to further develop the pipeline and strengthen its platform technology. CEO Bent U. Frandsen tells us more about ExpreS2ion's vision in today's BioStock Investor Pitch at 10:00.

Watch CEO Bent U. Frandsen present the company at biostock.se:

https://www.biostock.se/2022/04/biostock-investor-pitch-expres2ion-biotechnologies/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se